Conference item : Abstract
Tofacitinib improves composite endpoint measures of disease in patients with psoriatic arthritis
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 287.1KB)
-
- Publisher copy:
- 10.1136/annrheumdis-2018-eular.1275
Authors
Bibliographic Details
- Publisher:
- BMJ Publishing Group Publisher's website
- Journal:
- Annals of the Rheumatic Diseases Journal website
- Volume:
- 77
- Issue:
- S2
- Pages:
- 379-380
- Host title:
- Annals of the Rheumatic Diseases
- Publication date:
- 2018-06-12
- Acceptance date:
- 2018-03-15
- DOI:
- EISSN:
-
1468-2060
- ISSN:
-
0003-4967
- Source identifiers:
-
930947
Item Description
- Subtype:
- Abstract
- Pubs id:
-
pubs:930947
- UUID:
-
uuid:8a089bda-a133-4d45-a70f-262a222add23
- Local pid:
- pubs:930947
- Deposit date:
- 2019-06-06
Terms of use
- Copyright holder:
- Helliwell et al
- Copyright date:
- 2018
- Notes:
- Presented at the Annual European Congress of Rheumatology, EULAR 2018, 13-16 June 2018, Amsterdam.
If you are the owner of this record, you can report an update to it here: Report update to this record